Posts by: Anna Tan, RN

Anna Tan, RN

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

September 28, 2015September 28, 2015

Inhibrx, The Alpha-1 Project Partner to Advance Recombinant AAT for Emphysema

Emphysema, News

Inhibrx, a biologic therapeutic company focused on the treatment of high unmet medical needs in oncology, infectious disease and inflammatory conditions, and The Alpha-1 Project, Inc. (TAP), a wholly owned subsidiary of the Alpha-1 ... Read more

September 22, 2015September 22, 2015

Dr. Michael Boyle of CF Foundation Testifies in Front of Congress For Ensuring Access to Clinical Trials Act (EACT)

News

The Vice President of Therapeutics Development at the Cystic Fibrosis Foundation, Dr. Michael Boyle, was called in to testify last week in front of the House Energy and Commerce Committee’s Subcommittee ... Read more

September 17, 2015November 6, 2015

FDA Approves SPIRIVA Respimat as Asthma Maintenance Therapy

Asthma, News

One of the world’s leading pharmaceutical companies, Boehringer Ingelheim, has just announced its inhalation spray for COPD, SPIRIVA Respimat (tiotropium bromide), has received approval from the US Food and Drug Administration ... Read more

September 16, 2015September 16, 2015

NIH Grants $2.6 Million to Joint Research Project to Develop Mathematical Model for Cell Autophagy in Lung Cancer

Lung Cancer, News

A diverse team of disease and research experts is developing a mathematical model that can predict and demonstrate autophagy in lung cancer, which can potentially be used in discovering and advancing ... Read more

September 7, 2015September 7, 2015

US FDA Accepts Bristol-Myers Squibb’s sBLA for Opdivo (nivolumab) to Include Previously Treated Squamous NSCLC

Lung Cancer, News

The US Food and Drug Administration recently accepted Bristol-Myers Squibb Company’s supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) for review as a treatment for previously treated patients with non-squamous (NSQ) non-small cell ... Read more

September 3, 2015November 5, 2015

September is PFF’s Global Pulmonary Fibrosis Awareness Month

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation (PFF) kicks off its Global Pulmonary Fibrosis Awareness Month this September 2015, with a mission to better educate the public on the chronic and crippling disease, and at ... Read more

August 25, 2015November 5, 2015

Daiichi Sankyo Launches Worldwide Studies To Gauge Use of LIXIANA For Treating Pulmonary Embolism, Other Diseases

News, Pulmonary Hypertension

Daiichi Sankyo Europe GmbH announced enrollment of the first patient in the ETNA-AF-Europe (Edoxaban Treatment in routine clinical prActice – Atrial Fibrillation – Europe) registry, and the official launch of the ETNA-VTE-Europe (Edoxaban Treatment in routine clinical prActice – Venous ThromboEmbolism – Europe) ... Read more

August 21, 2015November 6, 2015

Allergy & Asthma Network Alerts Parents To Allergens and Asthma Triggers in School

Asthma, News

With school season in full swing for most children across the country, school staff and parents are making sure that students’ learning environment is as safe and healthy as it can ... Read more

August 13, 2015November 5, 2015

American Thoracic Society Recommends Esbriet (Pirfenidone) in Updated IPF Treatment Guidelines

Idiopathic Pulmonary Fibrosis, News

Esbriet (pirfenidone) by Genentech was recently included in the American Thoracic Society’s (ATS) updated idiopathic pulmonary fibrosis (IPF) treatment guidelines, which presents the drug’s proven benefits in delaying disease progression, as determined ... Read more

August 12, 2015November 9, 2015

Cipla Ltd. Set to Launch Novel Synchrobreathe Inhaler for Obstructive Airway Disease

COPD, News

Cipla Ltd., an Indian multinational pharmaceutical and biotechnology company headquartered in Mumbai, India, has announced it is set to launch a novel inhaler designed to effectively manage Obstructive Airway Disease (OAD). ... Read more